Oculis Holding AG Ordinary shares
Price & Volume
Stats
See more52W Range | $10.52-$34.47 |
Market Cap | $669.7M |
Shares Short | 651,247 |
Financials
See moreRevenue (12 Mos) | $1.1M |
Revenue Growth (YoY) | -26.7% |
Gross Profit (12 Mos) | -$55.2M |
Diluted EPS | -$2.11 |
News
See moreYahoo Finance • 8 hours ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
Yahoo Finance • 6 days ago
Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026
Yahoo Finance • 8 days ago
Oculis Announces First Patient Randomized in PREDICT-1 Registrational Trial of Licaminlimab, Advancing Precision Medicine in Dry Eye Disease
Yahoo Finance • 9 days ago
Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles
About
CEO | Dr. Riad Sherif M.B.A., M.D. |
Address | Bahnhofstrasse 20, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 60 |